1.
Clin Vaccine Immunol
; 14(3): 331-3, 2007 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17229882
RESUMO
Recombinant severe acute respiratory syndrome (SARS) nucleocapsid and spike protein-based immunoglobulin G immunoassays were developed and evaluated. Our assays demonstrated high sensitivity and specificity to the SARS coronavirus in sera collected from patients as late as 2 years postonset of symptoms. These assays will be useful not only for routine SARS coronavirus diagnostics but also for epidemiological and antibody kinetic studies.